ACE OncoCast
The official podcast feed of ACE Oncology. ACE provides evidence-based, high-quality independent medical education solutions that support clinicians in making up-to-date, appropriate treatment decisions. Listen to discussions among experts and stay informed on new data and best practices in the care of patients with cancer. The information in this podcast is provided for informational and educational purposes only.
ACE OncoCast
Updates on Oncogene-Driven NSCLC from Vienna: Osimertinib resistance
•
ACE Oncology
•
Season 4
•
Episode 3
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
In this episode, experts explore new data related to EGFR TKI resistance, specifically resistance to osimertinib. Listen to our experts evaluating the real-world data on most common resistance mechanisms to osimertinib and emerging strategies to overcome resistance.